Have your own idea? Try our Stock Screener
UPDATED Dec 20, 2024
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
300723 | CN¥20.80 | 2.7% | -29.7% | CN¥9.3b | CN¥26.24 | PS4.9x | E85.9% | 1.0% | ||
300871 | CN¥11.71 | -6.6% | -16.9% | CN¥1.9b | n/a | PS1.7x | E85.8% | 2.3% | ||
ROMJ | CA$0.43 | 14.7% | 2.4% | CA$24.3m | CA$1.10 | PB0.7x | E85.7% | n/a | ||
HROW | US$34.22 | -3.6% | 223.7% | US$1.2b | US$59.85 | PS7.2x | E85.3% | n/a | ||
MRVI | US$5.37 | -5.3% | -18.8% | US$1.4b | US$9.07 | PS2.8x | E84.7% | n/a | ||
AYTU | US$1.38 | -4.2% | -52.6% | US$8.5m | US$8.00 | PB0.3x | E84.7% | n/a | ||
STX | UK£0.027 | -0.9% | -57.8% | UK£21.3m | n/a | PS1.2x | E84.4% | n/a | ||
DXRX | UK£1.26 | 5.0% | 39.4% | UK£106.0m | UK£1.75 | PS4.1x | E83.5% | n/a | ||
CAMX | SEK 563.50 | 2.4% | 8.2% | SEK 33.1b | SEK 745.00 | PE124.5x | E83.1% | n/a | ||
SYBX | US$1.42 | -5.3% | -61.0% | US$16.0m | US$1.00 | PS6x | E82.9% | n/a | ||
688319 | CN¥11.72 | 0.5% | -22.5% | CN¥4.8b | n/a | PS9x | E82.0% | 0.3% | ||
CDXC | US$5.49 | -10.3% | 278.6% | US$414.1m | US$7.96 | PE283x | E81.8% | n/a | ||
ASRT | US$0.89 | -3.7% | -19.5% | US$80.5m | US$3.03 | PB0.6x | E81.3% | n/a | ||
NBY | US$0.53 | -7.8% | -93.3% | US$2.5m | US$3.73 | PB2.4x | E81.3% | n/a | ||
WEED | CA$4.04 | -8.6% | -40.7% | CA$410.9m | CA$6.15 | PS1.5x | E81.0% | n/a | ||
DERM | US$4.68 | -8.1% | -41.2% | US$97.1m | US$10.00 | PS1.7x | E79.9% | n/a | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
300639 | CN¥6.40 | -3.8% | -31.2% | CN¥4.1b | n/a | PS4.7x | E78.4% | 1.0% | ||
APPH | €10.10 | 0.5% | 117.7% | €84.1m | €13.25 | PS2.1x | E78.1% | n/a | ||
RCEL | US$11.77 | -3.6% | -11.1% | US$301.4m | US$16.84 | PS5.1x | E78.0% | n/a | ||
XOMA | US$27.13 | -0.07% | 47.4% | US$295.9m | US$89.00 | PS14.8x | E77.9% | n/a | ||
LABS | CA$0.065 | 0% | 8.3% | CA$26.7m | n/a | PB0.6x | E77.8% | n/a | ||
PRPH | US$0.61 | -6.2% | -86.8% | US$15.6m | US$18.50 | PS1.1x | E77.4% | 0% | ||
PPLPHARMA | ₹252.20 | 1.2% | 79.5% | ₹334.4b | ₹292.00 | PE737.6x | E77.2% | 0.04% |